Compare GLMD & DKI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GLMD | DKI |
|---|---|---|
| Founded | 2000 | 2018 |
| Country | Israel | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6M | 6.2M |
| IPO Year | 2014 | 2025 |
| Metric | GLMD | DKI |
|---|---|---|
| Price | $0.83 | $0.39 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 91.9K | ★ 122.5K |
| Earning Date | 11-26-2025 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 26.19 |
| Revenue | N/A | ★ $10,204,329.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.01 |
| Revenue Growth | N/A | ★ 100.46 |
| 52 Week Low | $0.73 | $0.30 |
| 52 Week High | $3.50 | $15.00 |
| Indicator | GLMD | DKI |
|---|---|---|
| Relative Strength Index (RSI) | 42.15 | N/A |
| Support Level | $0.73 | N/A |
| Resistance Level | $0.88 | N/A |
| Average True Range (ATR) | 0.07 | 0.00 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 41.20 | 0.00 |
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.
Darkiris Inc is a comprehensive technology enterprise engaged in the development, publishing and operating of mobile digital games via various third-party digital storefronts. Its activities encompass including game design, programming and graphics, as well as distribution and operation of mobile games on various platforms. Its core product offerings are Games Development; develop, market and distribute its self-developed mobile games; and Games Publishing and Operation. It publish and operate its self-developed mobile games and mobile games it license from other game developers.